New Jersey Pharmacist Pleads Guilty In Illegal Pharmaceutical Drug Distribution Scheme
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Breadcrumb

  • Home
  • New Jersey Pharmacist Pleads Guilty In Illegal Pharmaceutical Drug Distribution Scheme

New Jersey Pharmacist Pleads Guilty In Illegal Pharmaceutical Drug Distribution Scheme

September 07, 2011
|
Share Article
|
Download Press Release
For Immediate Release
Contact: Kenneth M. Heino
Phone Number: (571) 362-6616

NEWARK, N.J. - Brian R. Crowell, the Special Agent in Charge of the New Jersey Division of the Drug Enforcement (DEA) and Paul J. Fishman , the United States Attorney for the District of New Jersey, announced Vincent Hsia, a pharmacist and the former proprietor of Lincoln Pharmacy Network in Edison, N.J., admitted today that he conspired to distribute oxycodone and that he filed false personal and corporate income tax returns for tax years 2008 and 2009 which failed to report his proceeds from the scheme.

In connection with his guilty plea, Hsia, 51, of Flemington, N.J., pleaded guilty to five counts of the superseding Indictment against him: one count of conspiracy to distribute (Count One), and four counts of filing false individual and corporate tax (Counts 23-26). Hsia entered his guilty plea before U.S. District Judge Susan D. Wigenton following his arraignment on the charges in Newark federal court.

According to documents filed in the case and statements made in court:

Hsia admitted that he and at least eight co-conspirators participated in a conspiracy to distribute oxycodone, a Schedule II controlled substance, for no legitimate medical purpose and beyond the bounds of medical practice between October 4, 2007, and April 2, 2010. Specifically, Hsia admitted that he knowingly and intentionally filled fraudulent prescriptions for oxycodone completed in the names of fictitious patients.

Data obtained from the Automation of Reports and Consolidated System, through which manufacturers and distributors report sales of controlled substances, demonstrates that in 2007,

Lincoln Pharmacy’s purchases of oxycodone products totaled approximately 130,000 dosage units. In 2008, Lincoln Pharmacy purchased approximately 218,000 dosage units and purchased nearly 480,000 dosage units in 2009. The average dosage units purchased in 2009 by 171 pharmacies in Middlesex County, N.J., where Lincoln Pharmacy is located, was 101,514; by 1,966 pharmacies statewide was 78,817; and by 60,968 pharmacies nationwide was 62,927.

Hsia also admitted that he participated in the conspiracy in exchange for cash. He agreed that the approximately $600,000 seized by law enforcement at the time of his arrest was derived from the scheme. Hsia also admitted that he willfully subscribed to false individual tax returns and corporate tax returns on behalf of Lincoln Pharmacy, stating that those returns were materially false in that they did not report the true amount of cash Hsia made through the pharmacy in tax years 2008 and 2009.

The oxycodone conspiracy charge to which Hsia pleaded guilty carries a maximum potential penalty of 20 years in prison and a $1 million fine. The violations of the tax code to which Hsia pleaded guilty each carry a maximum potential penalty of three years in prison and a $100,000 fine. Sentencing is currently scheduled for December 12, 2011.

U.S. Attorney Fishman credited special agents of the DEA, under the direction of Special Agent in Charge Brian R. Crowell; the FBI, under the direction of Special Agent in Charge Michael B. Ward; IRS - Criminal Investigation, under the direction of Special Agent in Charge Victor W. Lessoff; the Newark, Elizabeth, and Nutley, N.J., police departments; and the Essex County Prosecutor’s and Sheriff’s Offices for the investigation leading to today’s guilty plea.

The government is represented by Assistant U.S. Attorneys Anthony J. Mahajan and Ronnell Wilson of the Narcotics/Organized Crime Drug Enforcement Task Force Unit in Newark.

Download Press Release
###
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

Cheryl Ortiz, Special Agent in Charge - New Jersey
@DEANewJerseyDiv
  • Facebook
  • X
  • Email

SAMHSA Behavioral Health Treatment Locator

  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster

United States Drug Enforcement Administration

Back
  • Who We Are
  • What We Do
  • Careers
  • Resources
Back
  • About
  • Mission
  • History
  • Divisions
  • DEA Museum
  • Wall of Honor
  • Contact Us
Back
  • Domestic Divisions
  • Foreign Divisions
  • Operational Divisions
Back
  • Submit a Tip
  • Extortion Scam
  • Public Affairs
  • Social Media Directory
Back
  • Forensic Sciences
  • Law Enforcement
  • Education and Prevention
  • Drug Information
  • News
  • Campaigns
Back
  • GUARDS
  • Forensic Sciences Policy
  • Forensic Science Organizations
  • Forensic Science Contact
Back
  • DEA Office of Training
  • El Paso Intelligence Center (EPIC)
  • Intelligence
  • Operations
Back
  • Office of Training Programs
Back
  • Administrative Law Judges
  • DEA Asset Forfeiture
  • Domestic Cannabis Suppression / Eradication Program
  • HIDTA
  • OCDETF
Back
  • Family Summit
  • Red Ribbon
  • Kiki and the History of Red Ribbon Week
  • Red Ribbon Toolkit - Resources For Your Community
  • DEA’s Family Summit
  • Operation Engage
  • Community Outreach
  • Just Think Twice
  • Campus Drug Prevention
  • Get Smart About Drugs
  • Operation Prevention
Back
  • Drug Policy
  • Drug Scheduling
  • The Controlled Substances Act
Back
  • Alerts
  • Press Releases
  • Most Wanted Fugitives
  • Stories
  • Events
  • Speeches
  • Testimony
Back
  • All Fugitives
Back
  • One Pill Can Kill
  • DEA National Prescription Drug Take Back Day
Back
  • Senior Citizens
  • Partner Toolbox
  • Social Media Campaign
Back
  • Special Agent
  • Diversion Investigator
  • Intelligence Research Specialist
  • Forensic Sciences Careers
  • Professional & Administrative Careers
  • Student & Entry Level Careers
  • Employment Eligibility
  • How to Apply
Back
  • Special Agent FAQs
Back
  • Diversion Investigator Job Announcement
Back
  • Intelligence Research Specialist Job Announcements
  • Intelligence Research Specialists FAQs
  • Schedule A Hiring Authority: Intelligence Research Specialist
Back
  • How To Claim Veterans' Preference
  • Priority Consideration
  • Benefits
  • Veterans and People With Disabilities
  • Operation Warfighter
Back
  • Illegal Online Pharmacies
  • OD Justice
  • Fentanyl Supply Chain
  • Pill Press Resources
  • Recovery Resources
  • Together for Families
  • Data and Statistics
  • FOIA
  • Publications
  • Media Galleries
  • Victim Witness Assistance Program
Back
  • Domestic Arrests
  • Staffing and Budget
Back
  • About FOIA
  • Contact DEA FOIA
  • Make a Request
  • What Happens After Making a Request
  • Requester Categories
  • Fees Charged
  • Fee Waiver
  • FOIA FAQ
  • FOIA Logs and Reports
  • FOIA Library
  • Additional FOIA Links
  • FOIA Exemptions
  • What Are Exclusions?
  • Privacy Act
  • Privacy Act Exemptions
  • Privacy Impact Assessment and Management Information Systems
Back
  • Victim Witness Assistance Program Resources
  • Human Trafficking Prevention
  • Submit A Tip +
  • Get Updates
  • Scam Alert
    • English
    • Español